Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Biliary Tract Cancer
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 1:1 randomization model to either Arm A or Arm BMasking: Single (Outcomes Assessor)Masking Description: Imaging scans will be assessed by blinded independent review according to RECIST v1.1Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04163900
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jennifer Knox, MD Professor of Medicine, University of Toronto
Get Well Soon